|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,273.90 INR | +0.71% |
|
-4.37% | +7.67% |
| 05-08 | Lupin Limited, Q4 2026 Earnings Call, May 08, 2026 | |
| 05-08 | Lupin's Consolidated Profit Rises in Fiscal Q4 | MT |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.5 | 3.46 | 2.38 | 7.39 | 9.77 | |||||
Return on Total Capital | 5.73 | 4.45 | 3.18 | 10.09 | 12.98 | |||||
Return On Equity % | 9.29 | -11.57 | 3.62 | 14.38 | 20.88 | |||||
Return on Common Equity | 9.24 | -11.77 | 3.49 | 14.31 | 20.84 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 62.11 | 57.94 | 56.54 | 64.46 | 67.5 | |||||
SG&A Margin | 19.22 | 18.78 | 19.14 | 17.96 | 17.97 | |||||
EBITDA Margin % | 16.65 | 11.98 | 9.45 | 18.13 | 22.24 | |||||
EBITA Margin % | 12.9 | 8.74 | 6.31 | 15.32 | 19.66 | |||||
EBIT Margin % | 11.54 | 7.67 | 5.12 | 13.87 | 18.31 | |||||
Income From Continuing Operations Margin % | 8.1 | -9.2 | 2.69 | 9.67 | 14.56 | |||||
Net Income Margin % | 8.02 | -9.31 | 2.58 | 9.57 | 14.45 | |||||
Net Avail. For Common Margin % | 8.02 | -9.31 | 2.58 | 9.57 | 14.45 | |||||
Normalized Net Income Margin | 6.61 | 4.89 | 2.6 | 8.01 | 11.03 | |||||
Levered Free Cash Flow Margin | 6.69 | 5.7 | 0.4 | 9.38 | -2.7 | |||||
Unlevered Free Cash Flow Margin | 7.08 | 6.01 | 1.2 | 10.16 | -2.04 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.62 | 0.72 | 0.74 | 0.85 | 0.85 | |||||
Fixed Assets Turnover | 2.93 | 3.09 | 3.04 | 3.63 | 4.13 | |||||
Receivables Turnover (Average Receivables) | 3.06 | 3.76 | 3.81 | 4.36 | 4.46 | |||||
Inventory Turnover (Average Inventory) | 1.52 | 1.58 | 1.59 | 1.51 | 1.42 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.66 | 1.51 | 1.34 | 1.58 | 1.87 | |||||
Quick Ratio | 1.06 | 0.78 | 0.8 | 0.93 | 1.08 | |||||
Operating Cash Flow to Current Liabilities | 0.22 | 0.04 | 0.2 | 0.43 | 0.33 | |||||
Days Sales Outstanding (Average Receivables) | 119.4 | 97.18 | 95.88 | 83.89 | 81.89 | |||||
Days Outstanding Inventory (Average Inventory) | 239.82 | 230.71 | 230.2 | 243.06 | 257.89 | |||||
Average Days Payable Outstanding | 126.63 | 105.43 | 123.87 | 132.64 | 136.61 | |||||
Cash Conversion Cycle (Average Days) | 232.59 | 222.46 | 202.21 | 194.3 | 203.17 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 37.01 | 34.02 | 36.21 | 20.33 | 31.5 | |||||
Total Debt / Total Capital | 27.01 | 25.39 | 26.58 | 16.89 | 23.95 | |||||
LT Debt/Equity | 1.98 | 2.98 | 1.71 | 1.08 | 11.74 | |||||
Long-Term Debt / Total Capital | 1.45 | 2.22 | 1.25 | 0.9 | 8.93 | |||||
Total Liabilities / Total Assets | 41.31 | 43.99 | 45.36 | 40.1 | 40.78 | |||||
EBIT / Interest Expense | 18.24 | 15.04 | 4 | 11.09 | 17.27 | |||||
EBITDA / Interest Expense | 27.38 | 24.69 | 7.88 | 14.96 | 21.49 | |||||
(EBITDA - Capex) / Interest Expense | 20.32 | 13.86 | 0.85 | 11.25 | 14.5 | |||||
Total Debt / EBITDA | 1.95 | 2.01 | 2.7 | 0.78 | 1.05 | |||||
Net Debt / EBITDA | 0.39 | 1.09 | 1.68 | 0.24 | 0.48 | |||||
Total Debt / (EBITDA - Capex) | 2.63 | 3.59 | 25.2 | 1.04 | 1.56 | |||||
Net Debt / (EBITDA - Capex) | 0.52 | 1.94 | 15.67 | 0.32 | 0.7 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -1.38 | 8.19 | 1.44 | 20.25 | 13.48 | |||||
Gross Profit, 1 Yr. Growth % | -1.86 | 0.92 | -1.01 | 37.09 | 18.82 | |||||
EBITDA, 1 Yr. Growth % | 7.83 | -22.11 | -19.97 | 130.53 | 39.24 | |||||
EBITA, 1 Yr. Growth % | 15.18 | -26.81 | -26.78 | 191.82 | 45.63 | |||||
EBIT, 1 Yr. Growth % | 27.67 | -28.28 | -32.24 | 225.65 | 49.82 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -407.07 | -222.92 | -129.66 | 332.35 | 70.82 | |||||
Net Income, 1 Yr. Growth % | -551.59 | -225.61 | -128.15 | 345.14 | 71.41 | |||||
Normalized Net Income, 1 Yr. Growth % | 14.29 | -20.2 | -45.99 | 269.88 | 56.35 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -402.8 | -225.95 | -127.96 | 344.95 | 71.22 | |||||
Accounts Receivable, 1 Yr. Growth % | -17.84 | -4.75 | 5.13 | 4.72 | 17.16 | |||||
Inventory, 1 Yr. Growth % | 18.37 | 13.17 | -3 | 10.29 | 10.55 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.16 | 3.11 | 2.64 | -0.82 | 0.17 | |||||
Total Assets, 1 Yr. Growth % | -5.5 | -7.58 | 5.2 | 4.54 | 21.7 | |||||
Tangible Book Value, 1 Yr. Growth % | 14.89 | -10.58 | -6.78 | 20.48 | 23.07 | |||||
Common Equity, 1 Yr. Growth % | 10.1 | -11.95 | 2.56 | 14.65 | 20.39 | |||||
Cash From Operations, 1 Yr. Growth % | 24.03 | -79.84 | 416.52 | 92.3 | -17.77 | |||||
Capital Expenditures, 1 Yr. Growth % | 0.67 | 33.57 | 65.69 | -38.06 | 81.12 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -31.59 | -7.69 | -92.81 | 2.7K | -132.69 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -36.18 | -7.98 | -79.69 | 914.93 | -122.77 | |||||
Dividend Per Share, 1 Yr. Growth % | 8.33 | -38.46 | 0 | 100 | 50 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.69 | 3.3 | 4.76 | 10.44 | 16.81 | |||||
Gross Profit, 2 Yr. CAGR % | 0.1 | -0.48 | -0.05 | 16.49 | 27.63 | |||||
EBITDA, 2 Yr. CAGR % | -0.73 | -8.35 | -21.05 | 35.83 | 79.17 | |||||
EBITA, 2 Yr. CAGR % | -2.66 | -8.08 | -26.79 | 46.18 | 106.15 | |||||
EBIT, 2 Yr. CAGR % | 1 | -4.19 | -30.29 | 48.54 | 120.88 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 53.52 | 94.28 | -39.62 | 13.24 | 171.76 | |||||
Net Income, 2 Yr. CAGR % | 41.62 | 138.16 | -40.54 | 11.93 | 176.23 | |||||
Normalized Net Income, 2 Yr. CAGR % | -3.19 | -4.37 | -34.35 | 41.34 | 140.48 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 53.91 | 95.29 | -40.66 | 11.54 | 176.02 | |||||
Accounts Receivable, 2 Yr. CAGR % | -6.79 | -11.54 | 0.07 | 4.92 | 10.76 | |||||
Inventory, 2 Yr. CAGR % | 3.27 | 15.74 | 4.77 | 3.43 | 10.42 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -6.05 | 2.64 | 2.88 | 0.89 | -0.33 | |||||
Total Assets, 2 Yr. CAGR % | -8.09 | -6.54 | -1.4 | 4.87 | 12.79 | |||||
Tangible Book Value, 2 Yr. CAGR % | 20.53 | 1.36 | -8.7 | 5.98 | 21.77 | |||||
Common Equity, 2 Yr. CAGR % | 0.22 | -1.54 | -4.97 | 8.44 | 17.48 | |||||
Cash From Operations, 2 Yr. CAGR % | 4.57 | -49.99 | 2.05 | 215.16 | 25.75 | |||||
Capital Expenditures, 2 Yr. CAGR % | -17.07 | 15.96 | 48.76 | 1.31 | 5.92 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 35.7 | -20.6 | -74.24 | 41.75 | 202.26 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 23.59 | -23.42 | -56.77 | 43.58 | 52.03 | |||||
Dividend Per Share, 2 Yr. CAGR % | 14.02 | -18.35 | -21.55 | 41.42 | 73.21 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -1.31 | 3.81 | 2.67 | 9.69 | 11.45 | |||||
Gross Profit, 3 Yr. CAGR % | -2.56 | 0.38 | -0.65 | 11.05 | 17.26 | |||||
EBITDA, 3 Yr. CAGR % | -6.83 | -8.44 | -12.4 | 12.85 | 36.96 | |||||
EBITA, 3 Yr. CAGR % | -8.36 | -11.42 | -14.79 | 16.08 | 45.99 | |||||
EBIT, 3 Yr. CAGR % | -5.15 | -9.82 | -14.64 | 16.53 | 48.97 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 68.13 | 42.55 | 3.84 | 16.38 | 29.87 | |||||
Net Income, 3 Yr. CAGR % | 69.17 | 36.07 | 16.88 | 16.32 | 29.02 | |||||
Normalized Net Income, 3 Yr. CAGR % | -6.14 | -9.15 | -20.95 | 16.82 | 46.18 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 68.96 | 43.96 | 2.16 | 16.15 | 28.67 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.84 | -6.11 | -6.3 | 1.6 | 8.85 | |||||
Inventory, 3 Yr. CAGR % | 3.77 | 6.47 | 9.12 | 6.58 | 5.75 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -3.71 | -3.09 | 2.64 | 1.63 | 0.65 | |||||
Total Assets, 3 Yr. CAGR % | -3.54 | -7.92 | -2.78 | 0.54 | 10.2 | |||||
Tangible Book Value, 3 Yr. CAGR % | 15.9 | 9.11 | -1.43 | 0.14 | 11.39 | |||||
Common Equity, 3 Yr. CAGR % | 0.55 | -4.01 | -0.19 | 1.16 | 12.28 | |||||
Cash From Operations, 3 Yr. CAGR % | 1.33 | -39.59 | 8.91 | 26.05 | 101.38 | |||||
Capital Expenditures, 3 Yr. CAGR % | -24.16 | -2.79 | 30.61 | 11.09 | 22.96 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 214.91 | 19.28 | -64.35 | 22.87 | -13.08 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 166.42 | 11.96 | -50.8 | 23.79 | -22.28 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.14 | -7.17 | -12.64 | 7.17 | 44.22 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.42 | -1.13 | 1.07 | 6.41 | 8.11 | |||||
Gross Profit, 5 Yr. CAGR % | -0.55 | -4.81 | -1.56 | 6.54 | 9.82 | |||||
EBITDA, 5 Yr. CAGR % | -7.45 | -15.55 | -12.8 | 7.21 | 16.63 | |||||
EBITA, 5 Yr. CAGR % | -9.99 | -18.83 | -16.2 | 8.23 | 21.33 | |||||
EBIT, 5 Yr. CAGR % | -11.61 | -19.32 | -16.1 | 10.11 | 24.86 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -11.56 | -10.06 | 11.62 | 30.01 | 52.57 | |||||
Net Income, 5 Yr. CAGR % | -11.66 | -9.79 | 11.35 | 25.85 | 64.87 | |||||
Normalized Net Income, 5 Yr. CAGR % | -13.47 | -18.41 | -18.6 | 8.42 | 23.36 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -11.76 | -9.83 | 11.18 | 29.99 | 52.04 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.33 | -0.21 | -2.9 | -1.84 | 0.19 | |||||
Inventory, 5 Yr. CAGR % | 4.56 | 4.92 | 4.17 | 5.24 | 9.64 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 3.86 | 0.17 | -1.13 | -1.52 | 1.44 | |||||
Total Assets, 5 Yr. CAGR % | 0.86 | -3.89 | -2.69 | -3 | 3.17 | |||||
Tangible Book Value, 5 Yr. CAGR % | 19.89 | 9.69 | 5.35 | 7.85 | 7.26 | |||||
Common Equity, 5 Yr. CAGR % | 4.34 | -2.08 | -1.7 | 0.79 | 6.53 | |||||
Cash From Operations, 5 Yr. CAGR % | 36.65 | -38.32 | 1.62 | 16.97 | 15.35 | |||||
Capital Expenditures, 5 Yr. CAGR % | -34.96 | -19.25 | -0.7 | -1.17 | 20.11 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -31.39 | -2.7 | 15.65 | 27.81 | -16.17 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -30.55 | -2.89 | 28.69 | 23.67 | -22.74 | |||||
Dividend Per Share, 5 Yr. CAGR % | -2.82 | -11.81 | -4.36 | 9.86 | 14.87 |
- Stock Market
- Equities
- 500257 Stock
- Financials Lupin Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















